“…These infections are recognized as being difficult to diagnose and treat [ 8 , 20 , 23 ], with patients having endured an average of 2.7 operations before definitive pathogen identification [ 13 , 23 ]. Once diagnosed, there exist no universal guidelines for the targeted management of fungal PJIs [ 9 , 13 , 20 , 24 , 25 ]. Despite a raft of varied approaches, fungal PJIs are associated with poorer outcomes [ 12 ] vs comparable bacterial infections; clearance (ie, cure) rates are lower [ 7 ] with far higher secondary failure rates [ 18 , 23 ], conversions to resection arthroplasties [ 7 , 23 ], amputation rates [ 17 ], and associated mortality [ 7 , 16 ].…”